These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34907224)

  • 1. A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus.
    Bhatia B; Meade-White K; Haddock E; Feldmann F; Marzi A; Feldmann H
    NPJ Vaccines; 2021 Dec; 6(1):152. PubMed ID: 34907224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates.
    Bhatia B; Tang-Huau TL; Feldmann F; Hanley PW; Rosenke R; Shaia C; Marzi A; Feldmann H
    Sci Adv; 2023 Sep; 9(36):eadj1428. PubMed ID: 37672587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.
    Shah SZ; Jabbar B; Ahmed N; Rehman A; Nasir H; Nadeem S; Jabbar I; Rahman ZU; Azam S
    Front Cell Infect Microbiol; 2018; 8():149. PubMed ID: 29868505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice.
    Lennemann NJ; Herbert AS; Brouillette R; Rhein B; Bakken RA; Perschbacher KJ; Cooney AL; Miller-Hunt CL; Ten Eyck P; Biggins J; Olinger G; Dye JM; Maury W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A VSV-based Zika virus vaccine protects mice from lethal challenge.
    Emanuel J; Callison J; Dowd KA; Pierson TC; Feldmann H; Marzi A
    Sci Rep; 2018 Jul; 8(1):11043. PubMed ID: 30038228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kyasanur Forest Disease and Alkhurma Hemorrhagic Fever Virus-Two Neglected Zoonotic Pathogens.
    Bhatia B; Feldmann H; Marzi A
    Microorganisms; 2020 Sep; 8(9):. PubMed ID: 32932653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
    Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell Culture.
    Cook BW; Ranadheera C; Nikiforuk AM; Cutts TA; Kobasa D; Court DA; Theriault SS
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004871. PubMed ID: 27479197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.
    Braxton CL; Puckett SH; Mizel SB; Lyles DS
    J Virol; 2010 Apr; 84(7):3552-61. PubMed ID: 20089648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
    Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
    mBio; 2019 May; 10(3):. PubMed ID: 31138743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kyasanur Forest disease virus infection in mice is associated with higher morbidity and mortality than infection with the closely related Alkhurma hemorrhagic fever virus.
    Dodd KA; Bird BH; Jones ME; Nichol ST; Spiropoulou CF
    PLoS One; 2014; 9(6):e100301. PubMed ID: 24950196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
    Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
    mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge.
    Marzi A; Reynolds P; Mercado-Hernandez R; Callison J; Feldmann F; Rosenke R; Thomas T; Scott DP; Hanley PW; Haddock E; Feldmann H
    EBioMedicine; 2019 Nov; 49():223-231. PubMed ID: 31631035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
    Locher S; Schweneker M; Hausmann J; Zimmer G
    J Gen Virol; 2018 Jul; 99(7):866-879. PubMed ID: 29869979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.
    Lingemann M; Liu X; Surman S; Liang B; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
    J Virol; 2017 May; 91(10):. PubMed ID: 28250127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.
    Lauretti F; Chattopadhyay A; de Oliveira França RF; Castro-Jorge L; Rose J; Fonseca BA
    Hum Vaccin Immunother; 2016 Sep; 12(9):2327-33. PubMed ID: 27185081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades.
    Furuyama W; Reynolds P; Haddock E; Meade-White K; Quynh Le M; Kawaoka Y; Feldmann H; Marzi A
    NPJ Vaccines; 2020; 5(1):4. PubMed ID: 31934358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.